Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)

Shandong Buchang Pharmaceuticals Revenue

Shandong Buchang Pharmaceuticals had revenue of 3.08B CNY in the quarter ending September 30, 2024, with 1.89% growth. This brings the company's revenue in the last twelve months to 11.78B, down -13.60% year-over-year. In the year 2023, Shandong Buchang Pharmaceuticals had annual revenue of 13.25B, down -11.41%.

• Revenue (ttm): 11.78B
• Revenue Growth: -13.60%
• P/S Ratio: 1.61
• Revenue / Employee: 1.42M
• Employees: 8,311
• Market Cap: 18.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	13.25B	-1.71B	-11.41%
Dec 31, 2022	14.95B	-811.43M	-5.15%
Dec 31, 2021	15.76B	-244.03M	-1.52%
Dec 31, 2020	16.01B	1.75B	12.28%
Dec 31, 2019	14.26B	590.70M	4.32%